Our news

  • In this blog dedicated to World Evidence-Based Healthcare Day, Cochrane Canada Investigator, Robby Nieuwlaat, describes the evolution of guideline development methodology and inclusivity in the guideline panel process.Blog Title: Learning to Develop Evidence-Based Healthcare Practice Guidelines in the INGUIDE ProgramWhen you visit your...
    October 18 2021
  • Director of Cochrane Canada, Holger Schünemann, and colleagues were recently awarded a contract from the World Health Organization (WHO) to develop with the WHO its new Handbook for quality assurance of its norms and standard-setting products, including the new version of the Guideline Development Handbook with updated and new chapters. The...
    October 6 2021
  • Nayaar Islam from The Ottawa Hospital Research Institute in Canada, describes the latest findings in this podcast interview. Listen to the podcast, view the transcript and the abstract at: https://www.cochrane.org/CD013639/INFECTN_how-accurate-chest-imaging-diagnosing-covid-19Why is this question important?People with suspected COVID-19...
    September 27 2021
  • Dear colleagues, members, supporters, and friends,It is with considerable regret that Cochrane’s Governing Board announces the cancellation of Cochrane Colloquium Toronto which had been rescheduled for 11-14th September, 2022. The Governing Board recently reviewed an options paper exploring a range of proposals for holding the planned...
    September 14 2021
  • September is Polycystic Ovary Syndrome Awareness Month and is an excellent time to focus on the latest Cochrane evidence.Polycystic ovary syndrome (PCOS) is a common condition affecting 8% to 13% of women in reproductive age. There are three main PCOS featuresmenstrual cycle problems, such as irregular periods or having no periods (meaning...
    September 13 2021
  • Cochrane Convenes will bring together key thought leaders from around the world to discuss the COVID-19 evidence response and develop recommendations to help prepare for and respond to future global health emergencies.In this interview, Cochrane Convenes talks to Jeremy Grimshaw, a member of the Cochrane Convenes steering group, about what he...
    September 8 2021
  • The burden of symptoms at the end of life of COVID-19 patients and helpful treatmentsCOVID-19 patients may show symptoms such as breathlessness or delirium at the end of life. The goal of palliative medicine is to relieve such symptoms with specific treatments. Treatments can be drugs, for example opioids, or non-drugs, such as breathing...
    August 30 2021
  • Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals. Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA...
    August 20 2021
  • Key messagesThe authors of this Cochrane systematic review, published today by Cochrane’s Infectious Diseases Group, found no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, but the evidence base is limited.Evaluation of ivermectin is continuing in 31 ongoing studies; the authors will update this review...
    August 9 2021
  • The Cochrane Methods team has defined a programme of work to improve the quality and impact of Cochrane reviews in public health with the support of the Methods Executive, Methods Groups and Public Health and Health Systems Network. The programme has been designed to foster collaboration between Methods Groups and...
    August 2 2021

Pages

      

Subscribe to Our news